PROCHYMAL™ (Human Adult Stem Cells) for the Treatment of Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)
Status:
Completed
Trial end date:
2010-08-24
Target enrollment:
Participant gender:
Summary
The objective of the present study is to establish the safety and efficacy of multiple
administrations of PROCHYMAL™ (human adult stem cells) in subjects with moderate to severe
Chronic Obstructive Pulmonary Disease (COPD).